The Centre for Human Genetics (CHG), formerly known as the Wellcome Centre for Human Genetics (WTCHG), is a world-renowned biomedical research institute based within the Nuffield Department of Medicine (NDM) in the Medical Sciences Division at the University of Oxford. Located in the Henry Wellcome Building of Genomic Medicine on the Old Road Campus in Headington, Oxford, the Centre operates at the forefront of human genetics, functional genomics, structural biology, and statistical genetics.
The primary mission of the Centre is to investigate the genetic foundations of human disease and variation. By examining the human genome at single-nucleotide and structural levels, CHG scientists decipher how genetic variants influence susceptibility to common, complex, and rare diseases. The Centre operates comprehensive, fee-for-service core facilities alongside cutting-edge research laboratories, serving internal academic groups, national research networks, international consortia, and commercial biomedical collaborators.
Core Activities and Research Focus Areas
The Centre for Human Genetics investigates disease etiology through a multi-disciplinary approach that connects basic DNA sequencing to molecular biology, structural analysis, and clinical translation. Its scientific activities span seven primary domains:
1. Complex Trait and Statistical Genetics
Genome-Wide Association Studies (GWAS): Mapping genetic variants linked to common multifactorial conditions across large population cohorts.
Population Genomics: Modeling human evolutionary history, genetic drift, linkage disequilibrium, and haplotype structures.
Computational Algorithm Development: Designing novel statistical models, imputation pipelines, and software tools to interpret petabyte-scale genetic data sets.
2. Cardiometabolic and Endocrine Disease
Type 2 Diabetes and Obesity: Characterizing loci associated with insulin resistance, beta-cell dysfunction, adiposity distribution, and metabolic dysregulation.
Cardiovascular Conditions: Investigating genomic determinants of atherosclerosis, hypertension, congenital heart disorders, and lipid metabolism.
3. Immunity, Inflammation, and Autoimmune Disorders
Autoimmune Pathogenesis: Investigating susceptibility genes for inflammatory bowel disease (IBD), rheumatoid arthritis, ankylosing spondylitis, and multiple sclerosis.
Innate and Adaptive Immune Signalling: Functional characterization of cytokine receptors, immune checkpoints, and inflammatory pathways.
4. Infectious Disease Susceptibility and Vaccine Response
Pathogen-Host Interaction Genomics: Partnering with institutes such as the Jenner Institute to understand host genetic determinants in infectious diseases such as malaria, tuberculosis, and viral infections.
Vaccinology Profiling: Identifying how genetic variation in human leukocyte antigens (HLA) and immune regulatory genes influences individual vaccine efficacy.
5. Neurogenetics and Developmental Conditions
Neurodegenerative and Psychiatric Disorders: Genetic mapping of monogenic and polygenic forms of Parkinson's disease, motor neuron disease (ALS), autism spectrum disorders, and cognitive conditions.
Functional Brain Genomics: Mapping gene expression across spatial neuroanatomy and cellular subtypes during development.
6. Structural and Cellular Biology
Protein Engineering and Macromolecular Complexes: Characterizing cell-surface receptors, viral glycoproteins, and signaling complexes.
Structure-Based Drug Discovery: Utilizing molecular insights to identify therapeutic targets and druggable pockets on disease-linked proteins.
Scientific Platforms, Core Facilities, and Services
The Centre for Human Genetics houses advanced core technology facilities. These facilities provide sample-to-result services, instrumentation access, assay development, and specialized scientific consulting:
Oxford Genomics Centre (OGC)
The OGC is the high-throughput genomics engine of the institute, providing comprehensive sequencing and array-based services for academic, clinical, and industrial clients:
* High-Throughput Sequencing (HTS / NGS): Short-read sequencing pipelines powered by Illumina platforms (NovaSeq, NextSeq, and MiSeq) for whole-genome sequencing (WGS), whole-exome sequencing (WES), and targeted gene panels.
* Long-Read Sequencing: Oxford Nanopore Technologies (PromethION, MinION) platforms enabling native DNA/RNA sequencing, structural variant resolution, and direct epigenetic base-modification detection.
* Single-Cell and Spatial Omics: Single-cell RNA-seq (scRNA-seq), single-cell ATAC-seq, and spatial transcriptomics technologies (such as 10x Genomics Chromium and Visium) for cellular heterogeneity analysis.
* Microarray and Methylation Profiling: High-density array platforms (Illumina Infinium, Fluidigm) supporting large-scale SNP genotyping, copy-number variation (CNV) screening, and epigenome-wide DNA methylation profiling.
* Quality Control and Library Preparation: Automated DNA/RNA extraction, quality assessment, and customized library preparation protocols for degraded, low-input, or formal-fixed paraffin-embedded (FFPE) biological materials.
Research Computing Core
The Research Computing Core delivers computational infrastructure engineered specifically for biomedical Big Data:
* High-Performance Compute (HPC) Clusters: Thousands of high-throughput compute cores managed via workload scheduling systems optimized for parallel bioinformatics pipelines.
* High-Capacity Biomedical Storage: Multi-petabyte resilient storage architectures configured for high-bandwidth data retrieval, security compliance, and long-term archival.
* Bioinformatics Infrastructure and Pipelines: Standardized analytical workflows for sequence alignment, variant calling, RNA expression quantification, and multi-omic data integration.
Cellular Imaging Core
The Cellular Imaging facility provides advanced light microscopy and imaging resources:
* Confocal and Super-Resolution Microscopy: High-resolution systems for cellular localization, protein-protein interactions, and live-cell dynamic imaging.
* Advanced Quantitative Techniques: Fluorescence Correlation Spectroscopy (FCS), Fluorescence Lifetime Imaging Microscopy (FLIM), and Total Internal Reflection Fluorescence (TIRF) microscopy.
* Image Analysis Solutions: Quantitative image analysis pipelines for high-content screening, cell tracking, and 3D spatial reconstructions.
Transgenic and Genome Engineering Core
This facility provides functional validation platforms for testing genetic variants in model systems:
* CRISPR/Cas9 Genome Editing: Design, validation, and delivery of targeted gene knockout, knockin, and point mutation systems in cellular lines and model organisms.
* Embryonic Stem Cell Manipulation: Gene targeting, selection, and microinjection services for creating genetically modified animal models.
* Cryopreservation and Rederivation: Line preservation, embryo freezing, IVF rederivation, and pathogen-free colony management.
Products, Computational Toolsets, and Resources
Beyond laboratory services, the Centre develops, curates, and distributes bioinformatics tools, software packages, reference datasets, and experimental protocols to the scientific community:
Open-Source Statistical and Bioinformatics Software
Imputation and Phasing Engines: Computational suites developed by CHG investigators (e.g., IMPUTE, SHAPEIT) that serve as global standards for estimating unobserved genotypes in GWAS cohorts.
Association Analysis Suites: Software packages (such as SNPTEST and related Bayesian frameworks) for testing association between genetic markers and phenotypic traits.
Genomic Quality Control Tools: Automated pipelines for sample identity verification, population stratification detection, and sequencing artifact filtering.
Data Resources and Biological Repositories
Consortium Data Repositories: Access points for summary statistics and processed datasets derived from landmark initiatives including the International HapMap Project, 1000 Genomes Project, and the Wellcome Trust Case Control Consortium (WTCCC).
Functional Annotation Maps: Epigenomic, expression quantitative trait loci (eQTL), and chromatin conformation maps linking non-coding genetic variants to downstream target genes.
Service and Collaboration Model
The Centre for Human Genetics operates through multiple engagement structures:
Please note: This information is generated by AI. For legal use, verify with company sources.
